April 13, 2026

PRECISEU launches Open Call to accelerate interregional innovation in personalised medicine

PRECISEU launches Open Call to accelerate interregional innovation in personalised medicine

Across Europe, the conversation around personalised medicine is no longer about potential—it is about implementation. The challenge is not only scientific progress, but how to move innovation across regions, systems and stakeholders in a coordinated way.

In this context, the PRECISEU project has launched its Open Call for Joint Interregional Projects (JIPs), opening on 13 April 2026, with the aim of supporting collaborative initiatives that bring together actors from different regions to develop and apply innovative healthcare solutions.

At its core, the call reflects a simple reality: meaningful progress in personalised medicine happens at the intersection of ecosystems. Research organisations, startups, healthcare providers and public actors each hold part of the solution. The Open Call is designed to connect these capabilities and enable projects that can move from concept to real-world application.

The focus is on interregional consortia, encouraging organisations to collaborate beyond national or institutional boundaries. These projects are expected to address shared healthcare challenges, strengthen regional innovation capacity and contribute to more effective and sustainable health systems.

Beyond funding, the initiative is part of a broader effort to create connected innovation ecosystems across Europe, where knowledge, data and practices can circulate more efficiently. PRECISEU itself was built around this objective—linking regions to accelerate the adoption of advanced therapies and data-driven healthcare solutions.

To support applicants, an information webinar on 14 April 2026 will provide guidance on the call’s objectives, eligibility criteria and application process, offering a practical entry point for those interested in building strong proposals.

📅 Key dates:

  • Open Call launch: 13 April 2026
  • Info webinar: 14 April 2026
  • Submission deadline: 14 June 2026

For organisations already working on innovation in personalised medicine, health data or advanced therapies, this is an opportunity to move beyond isolated initiatives and become part of cross-regional collaborations with tangible impact.

👉 Join the webinar and explore how to build your consortium: AVAILABLE HERE

Our latest News

discover more
Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved

Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved

Basel, Switzerland, 8 May 2026 – Today, Lonza Group Ltd held its Annual General Meeting (AGM), led by the Chair of the Board of Directors, Jean-Marc Huët. 62.58% of the share capital was represented at the AGM, with attending and represented shareholders collectively holding a total of 43,948,027 shares.  All Board members standing for re-election were re-elected, each for a further term in office until the completion of the AGM 2027. The following Board members stood for re-election: Jean-Marc Huët, Juan […]

A single swab is sufficient: Study paves the way for simplified tuberculosis diagnosis

A single swab is sufficient: Study paves the way for simplified tuberculosis diagnosis

Led by researchers from Heidelberg Faculty of Medicine at Heidelberg University and the University of California, San Francisco (USA), an international research team has evaluated a novel approach for the diagnosis of pulmonary tuberculosis. The method enables detection of Mycobacterium tuberculosis without laboratory infrastructure, within a markedly shorter time frame than conventional diagnostics, and using […]

Hella Bühler Prize Awarded to DKFZ Researcher Angelika Feldmann

Hella Bühler Prize Awarded to DKFZ Researcher Angelika Feldmann

For her groundbreaking research on the regulation of gene activity, Angelika Feldmann has been awarded the 2026 Hella Bühler Prize, which comes with a grant of €100,000. Presented by Heidelberg University, the award is intended for young researchers in the Heidelberg research community who have already distinguished themselves through outstanding scientific achievements in cancer research. […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp